g-Nomic: a new pharmacogenetics interpretation software

dc.contributor.authorSabater, Ana
dc.contributor.authorCiudad i Gómez, Carlos Julián
dc.contributor.authorCendros, Marc
dc.contributor.authorDobrokhotov, Denis
dc.contributor.authorSabater i Tobella, Joan, 1934-
dc.date.accessioned2020-06-15T15:34:07Z
dc.date.available2020-06-15T15:34:07Z
dc.date.issued2019-05-29
dc.date.updated2020-06-15T15:34:07Z
dc.description.abstractWe present g-Nomic, a pharmacogenetics interpretation software that analyzes globally a prescribed medication taking into account the personal background genetics, drug-drug interactions, lifestyle, nutritional supplements, inhibitors, inducers, and other risks to analyze primary or secondary metabolism pathways. G-Nomic provides a set of recommendations describing the suitability of a given combination of drugs for each patient according to their genes and polymedication. G-Nomic is updated monthly including data from the new drugs to be included, their known interactions, and the relevant pharmacokinetic biomarkers. For the interactions, the list is curated manually, only keeping those with clinical relevance. For each drug, their FDA and EMA drug labels are accessed, to check for relevant enzymes and transport proteins that influence its pharmacokinetics, and for their ability to induce or inhibit other enzymes, particularly the CYP-450 system. When this information is not available, a PubMed search is made to look for these characteristics. In addition, a distinction is made between drugs and prodrugs. A query on the g-Nomic software begins with entering the medication by either their common or commercial name. Non-pharmacological substances can be also added or selected under 'lifestyle habits'. The lifestyle list is dynamic, showing only the substances known to interact with the drugs that are currently selected, and includes herb compounds, such as St. John's wort, as well as proper lifestyle substances such as grapefruit or cigarette smoking. The software provides a list of the genes classified as primary biomarkers as candidates for genetic testing, and a list of the interactions that have been detected. If genetic information is available then, or is made available at a later point, these results can also be entered and the software returns pharmacogenetics recommendations regarding specific genotypes. g-Nomic takes all the above-mentioned parameters in an easy and user-friendly tool making prescription safer.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec690806
dc.identifier.issn1178-7066
dc.identifier.pmid31239753
dc.identifier.urihttps://hdl.handle.net/2445/165552
dc.language.isoeng
dc.publisherDove Medical Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.2147/PGPM.S203585
dc.relation.ispartofPharmacogenomics and Personalized Medicine, 2019, vol. 12, p. 75-85
dc.relation.urihttps://doi.org/10.2147/PGPM.S203585
dc.rightscc-by-nc (c) Sabater, Ana et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationFarmacogenètica
dc.subject.classificationMarcadors bioquímics
dc.subject.classificationProgramari
dc.subject.otherPharmacogenetics
dc.subject.otherBiochemical markers
dc.subject.otherComputer software
dc.titleg-Nomic: a new pharmacogenetics interpretation software
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
690806.pdf
Mida:
2.99 MB
Format:
Adobe Portable Document Format